Jarislowsky, Fraser LTD Boston Scientific Corp Transaction History

Jarislowsky, Fraser LTD

$14.9 Billion
Q2 2024

A detailed history of Jarislowsky, Fraser LTD transactions in Boston Scientific Corp stock. As of the latest transaction made, Jarislowsky, Fraser LTD holds 2,879,213 shares of BSX stock, worth $243 Million. This represents 1.49% of its overall portfolio holdings.

Number of Shares

2,879,213

Previous 2,962,910 2.82%

Holding current value

$243 Million

Previous $203 Million 9.26%

% of portfolio

1.49%

Previous 1.16%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$67.33 - $77.71 $5.64 Million - $6.5 Million	-83,697 Reduced 2.82%	2,879,213 $222 Million
Q1 2024 Sep 30, 2024	SELL	$57.6 - $68.62 $3.76 Million - $4.48 Million	-65,305 Reduced 2.16%	2,962,910 $203 Million
Q1 2024 May 13, 2024	SELL	$57.6 - $68.62 $3.76 Million - $4.48 Million	-65,305 Reduced 2.16%	2,962,910 $203 Million
Q4 2023 Sep 30, 2024	BUY	$48.64 - $57.81 $7.25 Million - $8.61 Million	149,002 Added 5.18%	3,028,215 $175 Million
Q4 2023 Feb 12, 2024	SELL	$48.64 - $57.81 $2.75 Million - $3.27 Million	-56,630 Reduced 1.84%	3,028,215 $175 Million
Q3 2023 Sep 30, 2024	BUY	$50.19 - $54.68 $10.3 Million - $11.2 Million	205,632 Added 7.14%	3,084,845 $163 Million
Q3 2023 Nov 06, 2023	SELL	$50.19 - $54.68 $2.32 Million - $2.53 Million	-46,273 Reduced 1.48%	3,084,845 $163 Million
Q2 2023 Sep 27, 2024	SELL	$49.72 - $54.64 $5.98 Million - $6.57 Million	-120,227 Reduced 3.7%	3,131,118 $169 Million
Q2 2023 Jul 19, 2023	SELL	$49.72 - $54.64 $5.98 Million - $6.57 Million	-120,227 Reduced 3.7%	3,131,118 $169 Million
Q1 2023 Sep 27, 2024	BUY	$45.09 - $50.03 $16.8 Million - $18.6 Million	372,132 Added 12.92%	3,251,345 $163 Million
Q1 2023 May 11, 2023	SELL	$45.09 - $50.03 $28.3 Million - $31.4 Million	-627,195 Reduced 16.17%	3,251,345 $163 Million
Q4 2022 Sep 27, 2024	BUY	$39.56 - $47.22 $39.5 Million - $47.2 Million	999,327 Added 34.71%	3,878,540 $179 Million
Q4 2022 Feb 10, 2023	SELL	$39.56 - $47.22 $10.7 Million - $12.8 Million	-270,811 Reduced 6.53%	3,878,540 $179 Million
Q3 2022 Nov 07, 2022	BUY	$36.71 - $109.66 $33,883 - $101,216	923 Added 0.02%	4,149,351 $161 Million
Q2 2022 Jul 27, 2022	SELL	$35.24 - $47.1 $8.1 Million - $10.8 Million	-229,772 Reduced 5.25%	4,148,428 $155 Million
Q1 2022 May 12, 2022	SELL	$40.9 - $45.1 $2.25 Million - $2.48 Million	-55,074 Reduced 1.24%	4,378,200 $194 Million
Q4 2021 Feb 10, 2022	BUY	$38.07 - $44.87 $332,807 - $392,253	8,742 Added 0.2%	4,433,274 $188 Million
Q3 2021 Nov 12, 2021	SELL	$41.23 - $45.88 $3.26 Million - $3.63 Million	-79,147 Reduced 1.76%	4,424,532 $192 Million
Q2 2021 Aug 09, 2021	SELL	$38.58 - $44.24 $55,439 - $63,572	-1,437 Reduced 0.03%	4,503,679 $193 Million
Q1 2021 May 13, 2021	BUY	$35.27 - $39.67 $3.25 Million - $3.66 Million	92,249 Added 2.09%	4,505,116 $174 Million
Q4 2020 Feb 11, 2021	BUY	$33.15 - $41.97 $29.2 Million - $37 Million	882,104 Added 24.98%	4,412,867 $159 Million
Q3 2020 Nov 03, 2020	BUY	$34.44 - $42.23 $16.3 Million - $19.9 Million	472,383 Added 15.45%	3,530,763 $135 Million
Q2 2020 Aug 12, 2020	BUY	$30.19 - $39.11 $6.6 Million - $8.55 Million	218,718 Added 7.7%	3,058,380 $107 Million
Q1 2020 May 13, 2020	BUY	$25.83 - $45.71 $18.3 Million - $32.3 Million	706,782 Added 33.14%	2,839,662 $92.7 Million
Q4 2019 Feb 13, 2020	BUY	$37.87 - $45.37 $8.45 Million - $10.1 Million	223,162 Added 11.69%	2,132,880 $96.4 Million
Q3 2019 Nov 13, 2019	BUY	$40.31 - $43.45 $22.4 Million - $24.2 Million	556,875 Added 41.16%	1,909,718 $77.7 Million
Q2 2019 Aug 13, 2019	BUY	$34.91 - $42.98 $47.2 Million - $58.1 Million	1,352,843 New	1,352,843 $58.1 Million

Others Institutions Holding BSX

# of Institutions

1,467

Shares Held

1.21B

Call Options Held

8.13M

Put Options Held

8.3M

View Full List

About BOSTON SCIENTIFIC CORP

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $121B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

More about BSX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jarislowsky, Fraser LTD, based on Form 13F filings with the SEC.

News

Stay updated on Jarislowsky, Fraser LTD with notifications on news.

Account

Jarislowsky, Fraser LTD Boston Scientific Corp Transaction History